ERVW-1 and infection: While the discovery of broadly neutralizing MAbs and the detection of broadly neutralizing polyclonal sera from HIV-1 infected individuals provides evidence that this goal is achievable [11], [12], evidence supporting the role of non-neutralising anti-Env antibodies in vaccine-induced protection from infection has been growing.